ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20 12月 2024 15:30:00 条件 Nasdaq GlobeNewswire

Ultragenyx Announces First Patient Dosed in Pivotal Phase 3 Aspire Study Evaluating GTX-102 in Angelman Syndrome

19 12月 2024 15:05:00 条件 Nasdaq GlobeNewswire

Ultragenyx Submits Biologics License Application to the U.S. FDA for UX111 AAV Gene Therapy for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)

19 12月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Ultragenyx to Participate in Investor Conferences in December

26 11月 2024 15:30:00 条件 Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20 11月 2024 15:30:00 条件 Nasdaq GlobeNewswire

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit

09 11月 2024 09:30:00 条件 Nasdaq GlobeNewswire

Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update

05 11月 2024 15:01:00 条件 Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Third Quarter 2024 Financial Results and Corporate Update

29 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 10月 2024 15:30:00 条件 Nasdaq GlobeNewswire

Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta

07 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease

03 10月 2024 15:30:00 条件 Nasdaq GlobeNewswire

Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting

26 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 9月 2024 16:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

16 9月 2024 11:51:10 条件 NetDania Notify

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

13 9月 2024 09:04:25 条件 NetDania Notify

Ultragenyx to Participate in Investor Conferences in September

29 8月 2024 15:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

29 8月 2024 09:17:24 条件 NetDania Notify

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

28 8月 2024 09:40:17 条件 NetDania Notify

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

26 8月 2024 11:35:19 条件 NetDania Notify

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

22 8月 2024 08:45:08 条件 NetDania Notify